Clinical Trial Update: Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated dosing regimens of eculizumab added to conventional treatment in positive crossmatch deceased donor kidney transplant; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Transplant | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-11-14